Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer

被引：1
|
作者：
Sg, Nithin [1 ]
Gogia, Ajay [1 ]
机构：
[1] All India Inst Med Sci AIIMS, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 08期
关键词：
D O I：
10.1200/JCO.22.02113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer
    Wander, Seth A.
    Spring, Laura M.
    Bardia, Aditya
    [J]. LANCET ONCOLOGY, 2019, 20 (06): : 746 - 748
  • [32] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    [J]. 中华医学杂志(英文版), 2020, 133 (19) : 2338 - 2345
  • [33] Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
    Lin, Mingxi
    Jin, Yizi
    Yang, Ziyi
    Hu, Xichun
    Zhang, Jian
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [34] Patterns of Progression in Hormone Receptor-Positive Metastatic Breast Cancer: An Argument for Local Therapy
    Rineer, J. M.
    Dvorak, T.
    Buchholz, D.
    Shah, N.
    Moroose, R.
    Kelly, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S275 - S275
  • [35] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [36] Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.
    Leitzel, Kim
    Ali, Suhail M.
    Vasekar, Monali K.
    Nagabhairu, Vinod
    Marks, Eric
    Ali, Ayesha
    Krecko, Laura
    Willumsen, Nicholas
    Leeming, Diana Julie
    Karsdal, Morten Asser
    Lipton, Allan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer
    Akiko Kawano
    Chikako Shimizu
    Kenji Hashimoto
    Takayuki Kinoshita
    Hitoshi Tsuda
    Hirofumi Fujii
    Yasuhiro Fujiwara
    [J]. Breast Cancer, 2013, 20 : 145 - 151
  • [38] Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
    Tanya E. Keenan
    Jennifer L. Guerriero
    Romualdo Barroso-Sousa
    Tianyu Li
    Tess O’Meara
    Anita Giobbie-Hurder
    Nabihah Tayob
    Jiani Hu
    Mariano Severgnini
    Judith Agudo
    Ines Vaz-Luis
    Leilani Anderson
    Victoria Attaya
    Jihye Park
    Jake Conway
    Meng Xiao He
    Brendan Reardon
    Erin Shannon
    Gerburg Wulf
    Laura M. Spring
    Rinath Jeselsohn
    Ian Krop
    Nancy U. Lin
    Ann Partridge
    Eric P. Winer
    Elizabeth A. Mittendorf
    David Liu
    Eliezer M. Van Allen
    Sara M. Tolaney
    [J]. Nature Communications, 12
  • [39] Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer
    Kawano, Akiko
    Shimizu, Chikako
    Hashimoto, Kenji
    Kinoshita, Takayuki
    Tsuda, Hitoshi
    Fujii, Hirofumi
    Fujiwara, Yasuhiro
    [J]. BREAST CANCER, 2013, 20 (02) : 145 - 151
  • [40] Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
    Keenan, Tanya E.
    Guerriero, Jennifer L.
    Barroso-Sousa, Romualdo
    Li, Tianyu
    O'Meara, Tess
    Giobbie-Hurder, Anita
    Tayob, Nabihah
    Hu, Jiani
    Severgnini, Mariano
    Agudo, Judith
    Vaz-Luis, Ines
    Anderson, Leilani
    Attaya, Victoria
    Park, Jihye
    Conway, Jake
    He, Meng Xiao
    Reardon, Brendan
    Shannon, Erin
    Wulf, Gerburg
    Spring, Laura M.
    Jeselsohn, Rinath
    Krop, Ian
    Lin, Nancy U.
    Partridge, Ann
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Liu, David
    Van Allen, Eliezer M.
    Tolaney, Sara M.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
12345